CClinicalTrials.gg
CompletedNCT03136250Updated Feb 8, 2018

Effects of Autogenic and Reciprocal Inhibition, Muscle Energy Techniques in the Management of Mechanical Neck Pain

An interventional study of Group A (Control Group - Static Stretching + Standard Treatment) and Group B (Autogenic Inhibition - PIR + Standard treatment) in Neck Pain, sponsored by Foundation University Islamabad. Completed at 1 site in Pakistan. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-02-08.

Sponsored by Foundation University Islamabad · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
78
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Neck pain is among the most common musculoskeletal disorders worldwide and is an important public health issue in terms of personal wellbeing. Prevalence of neck pain show excessive variations, with a point prevalence varying between 6% and 22%, and one year prevalence ranging between 1.5-75%. Neck pain like all other mechanical disorders leads to pain, disability and decreased range of motion (ROM). Stretching is a very common exercise performed by sportsmen, elderly, in physical therapy and rehabilitation patients, thus practiced in all sorts of fitness programs. The major types of stretching included in the literature are static, dynamic and pre-contraction stretching; of which static stretching is the conventional type of stretching. The different types of pre-contraction stretching include Proprioceptive Neuromuscular Facilitation (PNF) stretching, Post Isometric Relaxation (PIR), Post Facilitation stretch (PFS) and Active Isolated Stretch (AIS). Pre-contraction stretching is also considered a part of Muscle Energy Technique (MET). Recently MET and pre-contraction stretching have been shown to have significant superiority over conventional stretching in management of mechanical neck pain, but the evidence is currently lacking regarding which of the two pre-contraction stretching protocols, namely autogenic and reciprocal inhibition is more effective than the other. A RCT will be conducted in order to find and compare the effectiveness of conventional stretching and pre-contraction stretching (autogenic inhibition and reciprocal inhibition). One Control group (conventional group) and two Experimental groups (Experimental Group A - Autogenic Inhibition \& Experimental Group B - Reciprocal Inhibition) will be formed. The participants will be recruited in the study if they meet the inclusion criteria using consecutive sampling from Fauji Foundation Hospital and randomized into the three respective groups. All the groups will receive the gold standard treatment for chronic neck pain including mobilization and modalities. In addition to the gold standard treatment the participants will receive specific stretching protocol based on their interventional group

02

Conditions studied

  • Neck Pain

Browse trials for

Keywords

  • Muscle Energy Techniques
  • Autogenic Inhibition
  • Reciprocal Inhibition
  • Stretching
  • Range of Motion
  • Muscle Strength
  • VAS
  • Neck Disability Index
  • NDI
03

In context

Neck Pain

1,231 studies on the registry are indexed under Neck Pain; 254 are open to participants now.

This study's enrollment of 78 is above the median of 52 across 1,004 interventional studies indexed under Neck Pain.

Browse Neck Pain studies →

Lead sponsor

Foundation University Islamabad is the lead sponsor of 238 studies on the registry; 128 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Age 18 to 70 years;
  2. Neck pain on NPRS 4 to 8 (moderate cases);
  3. Subacute or chronic cases (4 to 12 weeks).
  4. Decreased or painful Cervical range of motion (CROM)

Exclusion criteria

Exclusion Criteria:

  1. Signs of serious pathology (e.g., malignancy, inflammatory disorder, infection);
  2. History of cervical spine surgery in previous 12 months;
  3. History of trauma or fractures in cervical spine;
  4. Signs of cervical radiculopathy or myelopathy; and
  5. Vascular syndromes such as VBI
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
78 participants (actual)

Study arms

  • Active comparator
    Group A (Control Group - Static Stretching)

    (Control Group - Static Stretching + Standard Treatment)

    Other: Group A (Control Group - Static Stretching + Standard Treatment)

  • Experimental
    Group B (Autogenic Inhibition MET)

    (Autogenic Inhibition - PIR + Standard treatment)

    Other: Group B (Autogenic Inhibition - PIR + Standard treatment)

  • Experimental
    Group C (Reciprocal Inhibition MET)

    (Reciprocal Inhibition - RI + Standard treatment)

    Other: Group C (Reciprocal Inhibition - RI + Standard treatment)

Interventions

  • OtherGroup A (Control Group - Static Stretching + Standard Treatment)

    o Conventional Gold Standard treatment (Manual Therapy + Modalities) Conventional Static Stretching 15-30 seconds hold 3-5 repetitions (Page P, 2012) for Ant/Middle/Posterior Scaleni, Sternocleidomastoid, Levator Scapulae and Upper Trapezius Muscles.

  • OtherGroup B (Autogenic Inhibition - PIR + Standard treatment)

    o Conventional Gold Standard treatment (Manual Therapy + Modalities) Post Isometric Relaxation MET (3-5 reps) for Ant/Middle/Posterior Scaleni, Sternocleidomastoid, Levator Scapulae and Upper Trapezius Muscles. (Chaitow L, 2006)

  • OtherGroup C (Reciprocal Inhibition - RI + Standard treatment)

    o Conventional Gold Standard treatment (Manual Therapy + Modalities) Reciprocal Inhibition MET (3-5 reps) for Ant/Middle/Posterior Scaleni, Sternocleidomastoid,Levator Scapulae and Upper Trapezius Muscles (Chaitow L, 2006)

06

What researchers measure

Primary outcomes

  1. Pain (Numeric Pain Rating Scale) - Change is being assessed

    To measure the pre and post patient's perception of pain

    Time frame: Pre-treatment (First day before treatment), Immediate Follow Up (After 1st treatment session) & Follow Up (After 5 days of Treatment)

  2. Cervical Range of Motion (CROM) - Change is being assessed

    To measure patient's improvement in cervical range of motion

    Time frame: Pre-treatment (First day before treatment), Immediate Follow Up (After 1st treatment session) & Follow Up (After 5 days of Treatment)

  3. Neck Disability Index (NDI) - Change is being assessed

    to measure patient's pre and post functional disability

    Time frame: Pre-treatment (First day before treatment), Immediate Follow Up (After 1st treatment session) & Follow Up (After 5 days of Treatment)

  4. Cervical Isometric Muscle Strength (Modified Sphygmomanometer dynamometry) - Change is being assessed

    To measure patient's improvement in Isometric Muscle Strength

    Time frame: Pre-treatment (First day before treatment), Immediate Follow Up (After 1st treatment session) & Follow Up (After 5 days of Treatment)

07

Study locations

1 site
  • Foundation University Institute of Rehabilitation Sciences
    Islamabad, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 8, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03136250
Lead sponsor
Foundation University Islamabad
Responsible party
Sponsor
First posted
May 2, 2017
Start date
Apr 11, 2017
Primary completion
Nov 30, 2017
Completion
Dec 30, 2017
Last update
Feb 8, 2018

Study contacts

Muhammad Osama, DPT, MS-OMPT, CHPE
principal investigator · Foundation University Islamabad

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion